These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33267758)

  • 1. CYP2C and CYP2B Mediated Metabolic Activation of Retrorsine in Cyp3a Knockout Mice.
    Pang X; Tang C; Kong F; Chen M; Chen X
    Curr Drug Metab; 2020; 21(13):1040-1051. PubMed ID: 33267758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Activation of Retrorsine may Disrupt Bile Acid Homeostasis in Mice through the Nrf2 Pathway.
    Pang X; Tang C; Cao P; Zhou L; Chen X
    Curr Drug Metab; 2021; 22(11):870-881. PubMed ID: 33906588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activity and induction of CYP2B, CYP2C, and CYP3A in tissues of cyclophosphane-sensitive and resistant neoplasms and the liver of neoplasm-carrying mice].
    Grishanov AIu; Kaledin VI; Zueva TV; Nekhoroshkova EK; Nikolin VP; Liakhovich VV
    Biomed Khim; 2003; 49(1):27-34. PubMed ID: 14569871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of CYP3A and CYP2B isoforms in hepatic bioactivation and detoxification of the pyrrolizidine alkaloid senecionine in sheep and hamsters.
    Huan JY; Miranda CL; Buhler DR; Cheeke PR
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):229-35. PubMed ID: 9707499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compensatory changes in CYP expression in three different toxicology mouse models: CAR-null, Cyp3a-null, and Cyp2b9/10/13-null mice.
    Kumar R; Mota LC; Litoff EJ; Rooney JP; Boswell WT; Courter E; Henderson CM; Hernandez JP; Corton JC; Moore DD; Baldwin WS
    PLoS One; 2017; 12(3):e0174355. PubMed ID: 28350814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP; Yan J; Fu PP; Chou MW
    Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, retrorsine, leading to DNA adduct formation in vivo.
    Wang YP; Fu PP; Chou MW
    Int J Environ Res Public Health; 2005 Apr; 2(1):74-9. PubMed ID: 16705803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of shenfu injection on CYP450s of rat liver].
    Li H; Wang YG; Ma ZC; Zhou SS; Liang QD; Xiao CR; Tan HL; Tang XL; Li H; Shen GL; Zhang BL; Gao Y
    Yao Xue Xue Bao; 2013 May; 48(5):728-33. PubMed ID: 23888697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of hepatic in vitro metabolism of the pyrrolizidine alkaloid senecionine in sheep and cattle.
    Duringer JM; Buhler DR; Craig AM
    Am J Vet Res; 2004 Nov; 65(11):1563-72. PubMed ID: 15566096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of spironolactone treatment on the cytochrome P450-mediated metabolism of the pyrrolizidine alkaloid senecionine by hepatic microsomes from rats and guinea pigs.
    Chung WG; Buhler DR
    Toxicol Appl Pharmacol; 1994 Aug; 127(2):314-9. PubMed ID: 8048076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of hepatic cyp2b and cyp3a subfamily enzymes by nicardipine and nifedipine in mice.
    Konno Y; Sekimoto M; Nemoto K; Degawa M
    Xenobiotica; 2004 Jul; 34(7):607-18. PubMed ID: 15672751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Disposition of Triazolam and Clobazam in Humanized CYP3A Mice with a Double-Knockout Background of Mouse
    Kobayashi K; Minegishi G; Kuriyama N; Miyajima A; Abe S; Kazuki K; Kazuki Y
    Drug Metab Dispos; 2023 Feb; 51(2):174-182. PubMed ID: 36379710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative PCR assay for cytochromes P450 2B and 3A induction in rat precision-cut liver slices: correlation study with induction in vivo.
    Cui X; Thomas A; Han Y; Palamanda J; Montgomery D; White RE; Morrison RA; Cheng KC
    J Pharmacol Toxicol Methods; 2005; 52(2):234-43. PubMed ID: 16125621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the impact of 16-dehydropregnenolone on the activity and expression of rat hepatic cytochrome P450 enzymes.
    Ramakrishna R; Bhateria M; Singh R; Bhatta RS
    J Steroid Biochem Mol Biol; 2016 Oct; 163():183-92. PubMed ID: 27224941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein Kinase N Family Negatively Regulates Constitutive Androstane Receptor-Mediated Transcriptional Induction of Cytochrome P450 2b10 in the Livers of Mice.
    Kawase A; Mukai H; Tateishi S; Kuroda S; Kazaoka A; Satoh R; Shimada H; Sugiura R; Iwaki M
    J Pharmacol Exp Ther; 2021 Oct; 379(1):53-63. PubMed ID: 34312179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rat and human liver cytochrome P-450 isoform metabolism of ecteinascidin 743 does not predict gender-dependent toxicity in humans.
    Reid JM; Kuffel MJ; Ruben SL; Morales JJ; Rinehart KL; Squillace DP; Ames MM
    Clin Cancer Res; 2002 Sep; 8(9):2952-62. PubMed ID: 12231541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic activation of retronecine and retronecine N-oxide - formation of DHP-derived DNA adducts.
    Yan J; Xia Q; Chou MW; Fu PP
    Toxicol Ind Health; 2008 Apr; 24(3):181-8. PubMed ID: 18842697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cytochrome P450IIIA4 in the metabolism of the pyrrolizidine alkaloid senecionine in human liver.
    Miranda CL; Reed RL; Guengerich FP; Buhler DR
    Carcinogenesis; 1991 Mar; 12(3):515-9. PubMed ID: 2009596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing regulation of cytochrome P450 expression by CAR and PXR in hypothyroid mice.
    Park YJ; Lee EK; Lee YK; Park DJ; Jang HC; Moore DD
    Toxicol Appl Pharmacol; 2012 Sep; 263(2):131-7. PubMed ID: 22503787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Chronic Renal Failure on Brain Cytochrome P450 in Rats.
    Naud J; Harding J; Lamarche C; Beauchemin S; Leblond FA; Pichette V
    Drug Metab Dispos; 2016 Aug; 44(8):1174-9. PubMed ID: 27271372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.